Circulating plasma cells in newly diagnosed symptomatic multiple myeloma as a possible prognostic marker for patients with standard‐risk cytogenetics

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 4, 2015-08 ,pp. : 523-531

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognostic significance of hepatocyte growth factor and microvessel bone marrow density in patients with chronic myeloid leukaemia

By Zhelyazkova A. G.   Tonchev A. B.   Kolova P.   Ivanova L.   Gercheva L.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 68, Iss. 6, 2008-10 ,pp. : 492-500

Informa Healthcare

Access to resources Recommend Favorite

NFKB1 −94ins/delATTG polymorphism is a novel prognostic marker in first line‐treated multiple myeloma

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 5, 2015-03 ,pp. : 679-688

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Impact of Mast Cell Density on the Progression of Bone Disease in Multiple Myeloma Patients

By  

International Archives of Allergy and Immunology, Vol. 168, Iss. 4, 2016-02 ,pp. : 263-268

Karger

Access to resources Recommend Favorite

Utilization of Magnetic-Activated Cell Sorting and High-Density Single Nucleotide Polymorphism Microarrays Improves Diagnostic Yield and Prognostic Value in Clinical Testing for Patients with Multiple Myeloma and Normal Routine Chromosome Study

By  

Acta Haematologica, Vol. 132, Iss. 2, 2014-04 ,pp. : 233-236

Karger

Access to resources Recommend Favorite